Skip to content

Versius or Laparoscopic TransAbdominal Inguinal Hernia REpair

A Single Blinded Randomised Controlled Trial Comparing the Ergonomics of Laparoscopic and Versius Robotic Assisted Inguinal Hernia Surgery

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05262374
Acronym
VOLTAIRE
Enrollment
60
Registered
2022-03-02
Start date
2023-02-09
Completion date
2024-04-05
Last updated
2025-03-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inguinal Hernia

Keywords

surgery, ergonomics, robotics

Brief summary

This trial will compare laparoscopic and robotic-assisted inguinal hernia repairs, using the Versius® system. We will initially aim to recruit 60 patients (20 patients in the laparoscopic arm and 40 in the robotic arm) in order to assess the ergonomic impact of each modality on the operating surgeon. This aims to provide in vivo information on whether robotic surgery provides any advantages to the operating surgeon. This trial will also be used to assess the feasibility of recruitment to a future larger study, and any data collected will be used as pilot data.

Detailed description

This study has been designed to assess the ergonomics of Versius® assisted surgery in comparison with laparoscopic surgery in the management of inguinal hernias. The study will randomise 60 patients who require repair of an inguinal hernia and have been deemed suitable for a minimally invasive approach. Patients will be randomised to receive either laparoscopic or Versius® robotic assisted surgery but will be informed that it will be attempted via a minimally invasive approach that could include either of these two subtypes of minimally invasive surgery. The randomisation will occur on a 2:1 basis, with 2 patients allocated to the robotic arm for every 1 patient allocated to the laparoscopic arm. Laparoscopic surgery is already a well-established technique, and therefore the study team believe more valuable data about the outcomes of robotic surgery will be obtained with this randomisation ratio given that no prior studies have been undertaken using this robotic platform. All surgeons in the study will be required to have been involved in at least 20 cases performed using the relevant modality, whether for the robotic or laparoscopic cohorts. Data will be collected at four key timepoints; recruitment, intraoperatively, at discharge and again at 14 days following intervention. Feasibility outcomes will include willingness to be recruited to study (acceptability), willingness for patient to undergo desired randomised operative approach (acceptability/concordance), withdrawal of patients (non-concordance), study retention (retention rates), and the usefulness and limitations of outcome measures.

Interventions

PROCEDUREProcedure/Surgery: Laparoscopic

Surgeon

PROCEDURERobotic

Versius system.

Sponsors

Milton Keynes University Hospital NHS Foundation Trust
Lead SponsorOTHER_GOV

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

* Age ≥18 years * Need for inguinal hernia repair surgery * Deemed suitable for minimally invasive surgery

Exclusion criteria

* Patients who are unable to consent * Prisoners * Patients in need of emergency surgery * Patients with inguinoscrotal or recurrent inguinal hernias

Design outcomes

Primary

MeasureTime frameDescription
To compare the operating surgeon ergonomics (physical strain) of laparoscopic and Versius® robotic assisted surgeryLength of the procedure expected to be between 1-4 hoursbody position (physical strain) and cognitive workload (mental strain) assessed using the REBA score

Secondary

MeasureTime frameDescription
Measurement of drop-out (withdrawal) rate of participantsAssessed from Day 1 (Randomisation) to date of withdrawalMeasure the number of participants who withdrawal (drop out) from the trial. The units of measurement will be presented on a scale of numbers of withdrawals versus time.
Measurement of the unblinding rate of participantsThrough study completion, an average of 1 year.Measure the number of participants where the treatment is unblinded during the trial. This is measured by the number of participants over the length of time who's treatment is unblinded.
Mental strain of surgeon30 minutes maximum completion time per surgeonTo compare the operating surgeon mental strain of each approach using the NASA-Task Load Index score.
Health EconomicsProcedure and recovery inpatient stay per participant expected to be between 1-3 days.Explore health economic aspects of each approach via calculation of the entire hospital episode and individual operation (including fixed costs and instrument costs) comparing the cost for cohort using the Versus Surgical Robot versus the human surgeon.
Measurement of the rate of participant recruitmentThrough study completion, an average of 1 year.Measure the number of participants recruited over the length of time. The units of measurement will be presented on a scale of number of participants over a predetermined length of time
Satisfaction with life scaleAssessed on Day 1 and Day 14Quality of life units completion of EQ-5D-5L questionnaires post operatively at recruitment Day 1 and on day 14. Total scores used not sub scales to be reported.
Satisfaction with lifeAssessed on Day 1 and Day 14Quality of life units completion of MFSI-SF questionnaires post operatively at recruitment Day 1 and on day 14. Total scores used not sub scales to be reported.
Length of in-patient stayThrough study completion, an average of 1 yearMeasure of the time in days of each participant's hospital stay as an in-patient.
Pain ScoresDay 14Using a uni-dimensional pain score measurement examining the change from baseline.
Communication1-4 hours expected for the duration of the procedureTo compare differences in in-theatre communication assessed from audiovisual footage, using the Oxford NOTECHS II score.

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026